The pathogenesis of chronic pain syndromes

References

• Sternbach R A. Chronic pain as a disease entity. Triangle (Sandoz) 1981; 20: 27–32
   PubMedGoogle Scholar
• Almay B GL. Patients with idiopathic pain syndromes. A clinical, biochemical and neuroendocrinological study. Umeå University Medical Dissertations. New series, Umeå university, Umeå 1987, No. 191
   Google Scholar
• Engel G. “Psychogenic” pain and the pain-prone patient. Am J Med 1959; 26: 899–918
   PubMed Web of Science ®Google Scholar
• Black RG. The chronic pain syndrome. Surg Clin North Am 1975; 55: 999–1011
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental DisordersThird Edition. American Psychiatric Association, Washington, DC 1980
   Google Scholar
• Lindsay P G, Wyckoff M. The depression-pain syndrome and its response to antidepressants. Psychosomatics 1981; 22: 571–7
   PubMed Web of Science ®Google Scholar
• Blumer D, Heilbronn M. Chronic pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis 1982; 170: 381–406
   PubMed Web of Science ®Google Scholar
• Williams J B, Spitzer RL. Idiopathic pain disorder: a critique of painprone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder. J Nerv Ment Dis 1982; 170: 415–9
   PubMed Web of Science ®Google Scholar
• Blumer D, Heilbronn M. Depression and chronic pain. Presentations of depression, O G Cameron. Wiley, New York 1987
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental DisordersThird revision - revised. American Psychiatric Association, Washington, DC 1987
   Google Scholar
• Ward N G, Bloom V L, Friedel RO. The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain 1979; 7: 331–41
   PubMed Web of Science ®Google Scholar
• von Knorring L, Perris C, Eisemann M, Eriksson U, Perris H. Pain as a symptom in depressive disorders. I. Relationship to diagnostic subgroup and depressive symptomatology. Pain 1983; 15: 19–26
   Web of Science ®Google Scholar
• Pilowsky I. Affective disorders and pain. Proceedings of the Vth World Congress on Pain., R Dubner, G F Gebhart, M R Bond. Elsevier Science Publishers, Amsterdam 1988; 263–275
   Google Scholar
• Sternbach RA. Pain patients. Traits and treatment. Academic Press, London 1974
   Google Scholar
• von Knorring L. The experience of pain in patients with depressive disorders. A clinical and experimental study. Umeå University Medical DissertationsNew Series No. 2. Umeå University, Umeå 1975
   Google Scholar
• Lopez Ibor JJ. Masked depression. Br J Psychiatry 1972; 120: 245–58
   PubMed Web of Science ®Google Scholar
• Blumer D, Heilbronn M. The pain-prone disorder: a clinical and' psychological profile. Psychosomatics 1981; 22: 395–402
   PubMed Web of Science ®Google Scholar
• Schaffer C B, Donlon P T, Bittle RM. Chronic pain and depression: a clinical and family history survey. Am J Psychiatry 1980; 137: 118–29
   PubMed Web of Science ®Google Scholar
• Katon W, Egan K, Miller D. Chronic pain: lifetime psychiatric diagnosis and family history. Am J Psychiatry 1985; 142: 1156–60
   PubMed Web of Science ®Google Scholar
• Perris C, Eisemann M, von Knorring L, Perris H. Personality traits in former depressed patients and in healthy subjects without past history of depression. Psychopathology 1984; 17: 178–86
   Google Scholar
• von Knorring L, Perris C, Eisemann M, Perris H. Discrimination of former depressed patients from healthy volunteers on the basis of stable personality traits assessed by means of KSP. Eur Arch Psychiatry Neurol Sci 1984; 234: 202–5
   PubMedGoogle Scholar
• von Knorring L, Almay B GL, Johansson F. Personality traits in patients with idiopathic pain disorder. Acta Psychiatry Scand 1987; 76: 490–8
   PubMed Web of Science ®Google Scholar
• Blumer D, Zorick F, Heilbronn M, Roth T. Biological markers for depression In chronic pain. J Nerv Ment Dis 1982; 170: 425–8
   PubMed Web of Science ®Google Scholar
• Kupfer D J, Foster FG. Interval between onset of sleep and rapid-eye movement sleep as an indicator of depression. Lancet 1972; 2: 684–6
   PubMed Web of Science ®Google Scholar
• Kupfer D J, Foster F G, Coble P, McPartland R J, Ulrich RF. The application of EEG sleep for the differential diagnosis of affective disorders. Am J Psychiatry 1978; 135: 69–74
   PubMed Web of Science ®Google Scholar
• Feinberg M, Carrol BJ. Biological “markers” for endogenous depression. Effect of age, severity of illness, weight loss, and polarity. Arch Gen Psychiatry 1984; 41: 1080–5
   PubMed Web of Science ®Google Scholar
• Kupfer DJ. EEG, sleep and tricyclic antidepressants in affective disorders. Clinical Pharmacology in Psychiatry, E Usdin. Elsevier, New York 1981; 325–38
   Google Scholar
• Akiskal H S, Rosenthal T L, Haykal R F, Lemmi H, Rosenthal R H, Scott-Strauss A. Characterological depressions. Clinical and sleep EEG findings separating “subaffective dysthymics” from “character-spectrum disorders”. Arch Gen Psychiat 1980; 37: 777–83
   PubMed Web of Science ®Google Scholar
• Thase M E, Kupfer D J, Spiker DG. Electroence-phalographic sleep in secondary depression: a revisit. Biol Psychiatry 1984; 19: 805–14
   PubMed Web of Science ®Google Scholar
• Katz J L, Kuperberg A, Pollack C P, Walsh B T, Zumoff B, Weiner H. Is there a relationship between eating disorder and affective disorders? New evidence from sleep recordings. Am J Psychiatry 1984; 141: 753–9
   PubMed Web of Science ®Google Scholar
• Carroll B J, Feinberg M, Greden F, et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 1981; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Hällström T, Samuelsson S, Balldin J, et al. Abnormal dexamethasone suppression test in normal females. Br J Psychiatry 1983; 142: 489–97
   PubMed Web of Science ®Google Scholar
• Coppen A, Abou-Saleh M, Milln P, Metcalfe M, Harwood J, Bailey J. Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 1983; 142: 498–504
   PubMed Web of Science ®Google Scholar
• Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967; 113: 1237–64
   PubMed Web of Science ®Google Scholar
• van Praag H M, Korf J, Schut D. Cerebral monoamines and depression. Arch Gen Psychiatry 1973; 28: 827–31
   PubMed Web of Science ®Google Scholar
• Åberg-Wistedt A. A double-blind study of zimeli-dine, a serotonin uptake inhibitor, and desipra-mine, a noradrenaline inhibitor, in endogenous depression. I. Clinical findings. Acta Psychiatr Scand 1982; 66: 50–65
   PubMed Web of Science ®Google Scholar
• Asberg M, Bertilsson L, Mårtensson B, Scalia-Tomba G-P, Thorén P, Träskman-Bendz L. CSF monoamine metabolites in melancholia. Acta Psychiatr Scand 1984; 69: 201–19
   PubMed Web of Science ®Google Scholar
• Messing R B, Lytle LD. Serotonin-containing neurons: their possible role in pain and analgesia. Pain 1977; 4: 1–21
   PubMed Web of Science ®Google Scholar
• Basbaum A I, Fields HL. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978; 4: 451–62
   PubMed Web of Science ®Google Scholar
• Sicuteri F, Anselmi B, Del Bianco PL. 5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical, pharmacological approach with p-chlorophenylalanine. Psychopharmacologia 1973; 29: 347–56
   PubMedGoogle Scholar
• Millinger GS. Neutral amino acid therapy for the management of chronic pain. Crani 1986; 4: 157–63
   PubMedGoogle Scholar
• Johansson F, von Knorring L. A double-blind controlled study of a serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients. Pain 1979; 7: 69–78
   PubMed Web of Science ®Google Scholar
• Ottevanger EA. Fluvoxamine – highly selective 5-Ht-reuptake inhibitor. (Basic broschure). Duphar, Holland 1987
   Google Scholar
• Eberhard G, von Knorring L, Nilsson H L, Sunde-Quist U, Björling G, Linder A, Svärd K O, Tysk L. A double blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes. Neuropsychobiology 1988; 19: 25–34
   PubMed Web of Science ®Google Scholar
• Almay B GL, Uggendal J, von Knorring L, Oreland L. 5-HIAA and HVA in CSF in patients with idiopathic pain disorders. Biol Psychiatry 1987; 22: 403–12
   PubMed Web of Science ®Google Scholar
• von Knorring L. Affect and pain: neurochemical mediators and therapeutic approaches. Proceedings of the Vth World Congress on Pain., R Dubner, G F Gebhart, M R Bond. Elsevier Science Publishers, Amsterdam 1988; 276–85
   Google Scholar
• Almay B GL, von Knorring L, Oreland L. Platelet MAO in patients with idiopathic pain disorders. J Neural Transm 1987; 69: 243–53
   PubMed Web of Science ®Google Scholar
• von Knorring L, Oreland L, Uggendal J, Magnusson T, Almay B, Johansson F. Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients. J Neural Transm 1986; 66: 37–46
   PubMed Web of Science ®Google Scholar
• Murphy D L, Wright C, Buchsbaum M, Nichols A, Costa J L, Wyatt RJ. Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem Med 1976; 16: 254–65
   Web of Science ®Google Scholar
• Reveley M A, Reveley A M, Clifford C A, Murray RM. Genetics of platelet MAO activity in discordant schizofrenic and normal twins. Br J Psychiatry 1983; 142: 560–5
   PubMed Web of Science ®Google Scholar
• Oxenstierna G, Edman G, Iselius L, Oreland L, Ross S B, Sedvall G. Concentrations of monoamine metabolites in CSF of twins and unrelated subjects. A genetic study. J Psychistric Res 1989, in press
   Google Scholar
• Hökfelt T, Ljungdahl Å, Steinbusch H, et al. Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the ratcentral nervous system. Neuroscience 1978; 3: 517–38
   PubMed Web of Science ®Google Scholar
• Almay B GL, Johansson F, von Knorring L, LeGrevés P, Terenius L. Substance P in CSF of patients with chronic pain syndromes. Pain 1988; 33: 3–9
   PubMed Web of Science ®Google Scholar
• Briley M S, Langer S Z, Raisman R, Sechter D, Zarifian E. Tritiated imipramine binding sites decreased in platelets of untreated depressed patients. Science 1980; 209: 303–5
   PubMed Web of Science ®Google Scholar
• Mellerup E T, Bech P, Hansen H J, Langemark M, Loldrup D, Plenge P. Platelet 3H-imipramine binding in psychogenic pain disorders. Psychiatry Research 1988; 26: 149–56
   PubMed Web of Science ®Google Scholar
• Eberhard G, von Knorring L, Mellerup E T, Nilssson H L, Plenge P, Sundequist U. 3H-imipra-mine binding in idiopathic pain syndromes. Basal values and changes after treatment with antidepressants. Pain 1989
   PubMed Web of Science ®Google Scholar
• Fuxe K, Calza L, Benfenati F, Zini I, Agnati LF. Quantitative autoradiographiclocalization of 3H-imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxytryptamine neuron systems. Proc Natl Acad Sci USA 1983; 80: 3836–40
   PubMed Web of Science ®Google Scholar
• Beck-Friis J. Melatonin in depressive disorders - a methodological and clinical study of the pineal-hypothalamic-pituitary-adrenal cortex system. Doctoral dissertation. Karolinska Institute, Stockholm 1983
   Google Scholar
• Almay B GL, von Knorring L, Wetterberg L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res 1987; 22: 179–91
   PubMed Web of Science ®Google Scholar
• von Knorring L, Terenius L, Wahlström A. Fraction 1 endorphin in cerebrospinal fluid. Clinical studies. Neurobiology of cerebrospinal fluid 2, J H Wood. Plenum Press, New York 1983; 83–96
   Google Scholar
• von Knorring L, Almay B GL, Ekman R, Widerlöv E. Biological markers in chronic pain syndromes. Nord Psykiatr Tidsskr 1988; 42: 139–45
   Google Scholar